1. Differences in integrated assessment and management of non-communicable diseases (NCDs) for people with HIV across the WHO European region. Kraef C, Singh S, Fursa O, Abutidze A, Rukhadze N, Mulabdic V, Yancheva N, Mehmeti M, Balayan T, Harxhi A, Trajanovska J, Mackintosh C, Duvivier C, Beniowski M, Jilich D, Reikvam DH, Tau L, Podlekareva D, Ryom L, Peters L, Kowalska J, Kirk O; EuroSIDA Study Group.
   HIV Med. 2024. Epub ahead of print. Abstract
    
2. SARS-CoV-2 testing, positivity, and factors associated with COVID-19 among people with HIV across Europe in the multinational EuroSIDA cohort. Fursa O, Bannister W, Neesgaard B, Podlekareva D, Kowalska J, Benfield T, Gerstoft J, Reekie J, Rasmussen LD, Aho I, Guaraldi G, Staub T, Miro JM, Laporte JM, Elbirt D, Trofimova T, Sedlacek D, Matulionyte R, Oprea C, Bernasconi E, Hadžiosmanović V, Mocroft A, Peters L; EuroSIDA Study Group.
   HIV Med. 2024. Epub ahead of print. Abstract
    
3. Associations between change in BMI and the risk of hypertension and dyslipidaemia in people receiving integrase strand-transfer inhibitors, tenofovir alafenamide, or both compared with other contemporary antiretroviral regimens: a multicentre, prospective observational study from the RESPOND consortium cohorts. Byonanebye DM, Polizzotto MN, Maltez F, Rauch A, Grabmeier-Pfistershammer K, Wit F, De Wit S, Castagna A, d'Arminio Monforte A, Mussini C, Wasmuth JC, Fontas E, Abela I, Sarcletti M, Bansi-Matharu L, Jaschinski N, Peters L, Hosein SR, Vannappagari V, Cohen C, Bissio E, Mocroft A, Law M, Ryom L, Petoumenos K; RESPOND study group.
   Lancet HIV. 2024;11(5):e321-e332. Abstract
    
4. Anemia in liver transplant recipients: prevalence, severity, risk factors, and survival. Hegland NØ, Rezahosseini O, Pedersen CR, Møller DL, Bugge TB, Wareham NE, Arentoft NS, Hillingsø J, Lund TK, Rasmussen A, Nielsen SD.
   APMIS. 2024;132(3):152-160. Abstract
    
5. Differences in toll-like receptor ligand-induced cytokine concentrations before and after solid organ transplantation: A prospective, observational cohort study in a clinical setting. Møller DL, Sørensen SS, Perch M, Gustafsson F, Hald A, Knudsen AD, Abdulovski R, Arentoft NS, Lundgren J, Rasmussen A, Ostrowski SR, Nielsen SD.
   Scand J Immunol. 2024;99(2):e13337. Abstract
    
6. Effect of Neutralizing Monoclonal Antibody Treatment on Early Trajectories of Virologic and Immunologic Biomarkers in Patients Hospitalized With COVID-19. Jensen TO, Grandits GA, Jain MK, Murray TA, Grund B, Shaw-Saliba K, Matthay MA, Abassi M, Ardelt M, Baker JV, Chen P, Dewar RL, Goodman AL, Hatlen TJ, Highbarger HC, Holodniy M, Lallemand P, Laverdure S, Leshnower BG, Looney D, Moschopoulos CD, Mugerwa H, Murray DD, Mylonakis E, Nagy-Agren S, Rehman MT, Rupert A, Stevens RA, Turville S, Weintrob A, Wick K, Lundgren J, Ko ER; ACTIV-3/TICO Study Group.
   J Infect Dis. 2024;229(3):671-679. Abstract
    
7. ExplaineR: an R package to explain machine learning models. Zargari Marandi R.
   Bioinform Adv. 2024;4(1):vbae049. Abstract
    
8. The association between single-nucleotide polymorphisms within type 1 interferon pathway genes and human immunodeficiency virus type 1 viral load in antiretroviral-naïve participants. Mørup SB, Leung P, Reilly C, Sherman BT, Chang W, Milojevic M, Milinkovic A, Liappis A, Borgwardt L, Petoumenos K, Paredes R, Mistry SS, MacPherson CR, Lundgren J, Helleberg M, Reekie J, Murray DD; INSIGHT FIRST and START study groups.
   AIDS Res Ther. 2024;21(1):27. Abstract
    
9. Trends in mortality in people with HIV from 1999 to 2020: a multi-cohort collaboration. Tusch E, Ryom L, Pelchen-Matthews A, Mocroft A, Elbirt D, Oprea C, Günthard HF, Staehelin C, Zangerle R, Suarez I, Vehreschild JJ, Wit F, Menozzi M, d'Arminio Monforte A, Spagnuolo V, Pradier C, Carlander C, Suanzes P, Wasmuth JC, Carr A, Petoumenos K, Borgans F, Bonnet F, De Wit S, El-Sadr W, Neesgaard B, Jaschinski N, Greenberg L, Hosein SR, Gallant J, Vannappagari V, Young L, Sabin C, Lundgren J, Peters L, Reekie J; D:A:D cohort study; RESPOND cohort study.
   Clin Infect Dis. 2024:ciae228. Abstract
    
10. Trends in underlying causes of death in allogeneic hematopoietic cell transplant recipients over the last decade. Søborg A, Reekie J, Sengeløv H, Da Cunha-Bang C, Lund TK, Ekenberg C, Lodding IP, Moestrup KS, Lundgren L, Lundgren JD, Wareham NE.
    Eur J Haematol. 2024;112(5):802-809. Abstract
     
11. Long-term impact of immediate versus deferred antiretroviral therapy on kidney health in people with HIV. Pelchen-Matthews A, Mocroft A, Ryom L, Ross MJ, Sharma S, Coca S, Achhra A, Cornell E, Tracy R, Phillips A, Alonso MM, Toulomi G, Agan BK, Medland N, Wyatt CM; INSIGHT START Study Group.
    Kidney Int. 2024:S0085-2538(24)00313-2. Epub ahead of print. Abstract
     
12. Development of antibody levels and subsequent decline in individuals with vaccine induced and hybrid immunity to SARS-CoV-2. Reekie J, Stovring H, Nielsen H, Johansen IS, Benfield T, Wiese L, Stærke NB, Iversen K, Mustafa AB, Petersen KT, Juhl MR, Knudsen LS, Iversen MB, Andersen SD, Larsen FD, Baerends EAM, Lindvig SO, Rasmussen LD, Madsen LW, Bannister W, Jensen TO, Dietz LL, Ostrowski SR, Østergaard L, Tolstrup M, Lundgren JD, Søgaard OS; ENFORCE study group.
    Int J Infect Dis. 2024:107111. Abstract
     
13. The HepHIV 2023 Madrid conference: A call to action for political leadership in reaching the sustainable development goals on earlier testing and linkage to care for HIV, viral hepatitis, and sexually transmitted infections.  Simões D, Raben D, Moran AB, Imaz A, Stengaard AR, Raahauge A, Sullivan AK, Vaughan E, Brännström J, De Baetselier I, Platteau T, Casabona J, Del Amo J; 2023 HepHIV Conference Organising Committee and the EuroTEST Steering Committee.
    HIV Med. 2024. Epub ahead of print. Abstract
     
14. All-cause and AIDS-related mortality among people with HIV across Europe from 2001 – 2020: impact of antiretroviral therapy, and regional differences in a multicentre cohort study Christian Kraef, Erich Tusch, Sabine Singh, Lars Østergaard, Gerd Fätkenheuer, Antonella Castagna, Santiago Moreno, Katharina Kusejko, Bartosz Szetela, Anastasiia Kuznetsova, Janez Tomažič, Jovan Ranin, Robert Zangerle, Fredrik Mansson, Giulia Marchetti, Stéphane De Wit, Amanda Clarke, Jan Gerstoft, Daria Podlekareva, Lars Peters, Joanne Reekie, Ole Kirk, and the EuroSIDA Study Group.
    The Lancet Regional Health - Europe 2024;44: 100989. Abstract 
     
15. Chronic liver enzyme elevation and use of contemporary ARVs among persons living with HIV. Ashley O Roen, Lars Peters, Gilles Wandeler, Marc van der Valk, Robert Zangerle, Huldrych F Günthard, Ferdinand Wit, Cristina Mussini, Stéphane De Wit, Antonella d’Arminio Monforte, Jörg Janne Vehreschild, Antonella Castagna, Nadine Jaschinski, Vani Vannappagari, Linda Chen, Joan Tallada, John C’mar, Amanda Mocroft, Lene Ryom
    Open Forum Infectious Diseases, 2024;11(6): ofae308 Abstract

IN PRESS